Biblio
Precision Medicine in Parkinson's Disease using Induced Pluripotent Stem Cells. Adv Healthc Mater. 2024:e2303041.
. Advanced human iPSC-based preclinical model for Parkinson's disease with optogenetic alpha-synuclein aggregation. Cell Stem Cell. 2023.
. Optogenetic induction of alpha-synuclein aggregation in human dopaminergic neurons to model Parkinson's disease pathology. STAR Protoc. 2023;4(4):102609.
. . .